预防性纤维素素可减少关节整形手术中的过度出血:一项随机双盲安慰剂对照试验
The archives of bone and joint surgery
|May 13, 2024
概括
术前使用纤维素缩剂显著减少了关节整形术患者的血液损失和输血需求. 这种安全的干预措施是管理外科手术期间出血的有希望的策略.
科学领域:
- 整形外科手术 整形外科手术
- 麻醉学 麻醉学
- 血液学 血液学 血液学
背景情况:
- 过度的血液流失是关节整形术 (THA) 的重要并发症.
- 管理术后出血对于患者的结果和资源利用至关重要.
研究的目的:
- 为了评估手术前纤维素缩剂的有效性,以减少血液损失.
- 为了确定纤维素度是否减少了在THA手术期间输血的需要.
主要方法:
- 这是一项双盲,随机对照试验,涉及178名接受THA治疗的患者.
- 患者在手术前30分钟接受了静脉注射纤维素缩物或安慰剂盐溶液.
- 主要结局是术后失血;次要结局是需要输血.
主要成果:
- 与安慰剂相比,纤维素度显著减少了手术后的血液损失 (P=0.001).
- 在纤维素原组 (P=0.004) 中,对输血的需求也显著降低 (P=0.004).
- 没有报告任何不良副作用;纤维素原组在手术后显示出更好的血红蛋白和纤维素原水平.
结论:
- 在手术前给药纤维素缩剂是有效的减轻血液损失.
- 纤维素缩物减少了在全关节整形术中对输血的要求.
- 这种干预提供了一种安全有效的方法来管理THA中的出血并发症.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
686
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
Clot Retraction and Fibrinolysis
5.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
521
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521
Extrinsic and Intrinsic Pathways of Hemostasis
7.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.3K
Disorders of Hemostasis
862
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
862
Introduction to Hemostasis
7.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.4K


